SCHEMBL7375453

SCHEMBL7375453

O=C(Nc1ccccc1)NC1C(=O)N(CC23CC4CC(CC(C4)C2)C3)c2ccccc2N(c2ccccc2)C1=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CCKBR P32239 18/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8635663 0.92 CCKBR (1.00) CCKBR
SCHEMBL8635695 0.91 CCKBR (1.00) CCKBR
SCHEMBL8636478 0.91 CCKBR (1.00) CCKBR
SCHEMBL8659328 0.91 CCKBR (1.00) CCKBR
SCHEMBL8656811 0.91 CCKBR (1.00) CCKBR
SCHEMBL8656788 0.90 CCKBR (0.82) CCKBR
SCHEMBL8867367 0.89 CCKBR (0.88) CCKBR
SCHEMBL1388061 0.89 CCKBR (0.88) CCKBR
SCHEMBL8638672 0.89 CCKBR (0.81) CCKBR
SCHEMBL8635744 0.89 CCKBR (1.00) CCKBR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6413930-B1 CONTROLLING EYE MOVEMENT GLAXO WELLCOME SPA (IT) 2002-07-02 US claimed
EP-0785788-B1 USE OF CCK-B RECEPTOR ANTAGONISTS FOR THE TREATMENT OF SLEEP DISORDERS GLAXO WELLCOME SPA (IT) 2001-12-12 EP claimed
EP-0828479-B1 METHOD OF PRODUCING A SOLID DISPERSION OF A POORLY WATER SOLUBLE DRUG ICOS CORP (US) 2001-10-24 EP claimed
US-5985326-A MIXING WITH SOLVENT; COPRECIPITATION; 2,3,6,7,12,12A-HEXAHYDRO-2-METHYL-6-(3,4-METHYLENEDIOXYPHENYL) -PYRAZINO(2',1':6,1)PYRIDO(3,4-B)INDOLE-1,4-DIONE ICOS CORPORATION (US) 1999-11-16 US claimed
EP-0558104-B1 1,5-Benzodiazepine derivatives and their use in medicine GLAXO WELLCOME SPA (IT) 1998-07-29 EP claimed
EP-0828479-A1 METHOD OF PRODUCING A SOLID DISPERSION OF A POORLY WATER SOLUBLE DRUG GLAXO GROUP LIMITED (GB) 1998-03-18 EP claimed
EP-0785788-A1 USE OF CCK-B RECEPTOR ANTAGONISTS FOR THE TREATMENT OF SLEEP DISORDERS GLAXO WELLCOME S.p.A. (IT) 1997-07-30 EP claimed
WO-1996038131-A1 METHOD OF PRODUCING A SOLID DISPERSION OF A POORLY WATER SOLUBLE DRUG GLAXO GROUP LIMITED (GB) 1996-12-05 WO claimed
WO-1996011689-A1 USE OF CCK-B RECEPTOR ANTAGONISTS FOR THE TREATMENT OF SLEEP DISORDERS GLAXO WELLCOME SPA (IT) 1996-04-25 WO claimed
EP-0558104-A1 1,5-Benzodiazepine derivatives and their use in medicine GLAXO S.p.A. (IT) 1993-09-01 EP claimed
WO-1993014074-A1 1,5-BENZODIAZEPINE DERIVATIVES AND THEIR USE IN MEDICINE GLAXO SPA (IT) 1993-07-22 WO claimed
JP-7118244-A None JP disclosed
US-6413930-B1 CONTROLLING EYE MOVEMENT GLAXO WELLCOME SPA (IT) 2002-07-02 US disclosed
EP-0785788-B1 USE OF CCK-B RECEPTOR ANTAGONISTS FOR THE TREATMENT OF SLEEP DISORDERS GLAXO WELLCOME SPA (IT) 2001-12-12 EP disclosed
EP-0828479-B1 METHOD OF PRODUCING A SOLID DISPERSION OF A POORLY WATER SOLUBLE DRUG ICOS CORP (US) 2001-10-24 EP disclosed
US-5580895-A GASTROINTESTINAL OR CENTRAL NERVOUS SYSTEM DISORDERS GLAXO SPA (IT) 1996-12-03 US disclosed
WO-1996011689-A1 USE OF CCK-B RECEPTOR ANTAGONISTS FOR THE TREATMENT OF SLEEP DISORDERS GLAXO WELLCOME SPA (IT) 1996-04-25 WO disclosed
JP-H07118244-A 1,5-BENZODIAZEPINE DERIVATIVE GLAXO SPA 1995-05-09 JP disclosed
EP-0558104-A1 1,5-Benzodiazepine derivatives and their use in medicine GLAXO S.p.A. (IT) 1993-09-01 EP disclosed
WO-1993014074-A1 1,5-BENZODIAZEPINE DERIVATIVES AND THEIR USE IN MEDICINE GLAXO SPA (IT) 1993-07-22 WO disclosed